Platelet-derived CXC chemokines: old players in new games

被引:136
作者
Brandt, E [1 ]
Ludwig, A [1 ]
Petersen, F [1 ]
Flad, HD [1 ]
机构
[1] Res Ctr Borstel, Dept Immunol & Cell Biol, D-23845 Borstel, Germany
关键词
D O I
10.1034/j.1600-065X.2000.17705.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although platelet factor 4 (PF-4) and the beta -thromboglobulin (beta -TG) proteins represent the first chemokines to be discovered, their functional roles in host defense became clear only recently. Residing in platelets as storage proteins and becoming released into the blood at very high concentrations, these mediators appear to fulfill different and complementary tasks as first-line mediators in the recruitment and activation of leukocytes, as well in the regulation of tissue repair. Whereas both proteins are structurally closely related members of the CXC chemokine subfamily, they are subject to quite dissimilar regulatory mechanisms controlling their generation and their spectrum of biological activities. Thus, proteolytic processing of inactive precursors plays a decisive role in whether the beta -TG proteins will act as stimulatory or inhibitory agents in neutrophil activation via the G protein-coupled receptors CXCR-1 and 2. PF-4, existing as a single molecular form, is largely resistant to proteolytic modification, but its interaction with an unusual recepror(s) on leukocytes (a proteoglycan) appears to depend on its oligomeric stare. There is growing evidence that both chemokines may interfere with each other at various regulatory levels to promote coordinated cell activation. Moreover, recent findings suggest novel and unexpected activities for these chemokines, which may extend our view on early host defense.
引用
收藏
页码:204 / 216
页数:13
相关论文
共 79 条
  • [11] CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128
  • [12] CLARKLEWIS I, 1994, J BIOL CHEM, V269, P16075
  • [13] PLATELET FACTOR-IV BINDS TO INTERLEUKIN-8 RECEPTORS AND ACTIVATES NEUTROPHILS WHEN ITS N-TERMINUS IS MODIFIED WITH GLU-LEU-ARG
    CLARKLEWIS, I
    DEWALD, B
    GEISER, T
    MOSER, B
    BAGGIOLINI, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) : 3574 - 3577
  • [14] GENERATION OF THE NEUTROPHIL-ACTIVATING PEPTIDE-2 BY CATHEPSIN-G AND CATHEPSIN G-TREATED HUMAN PLATELETS
    COHEN, AB
    STEVENS, MD
    MILLER, EJ
    ATKINSON, MAL
    MULLENBACH, G
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (02): : L249 - L256
  • [15] RELEASE, DISTRIBUTION, AND CLEARANCE OF HUMAN BETA-THROMBOGLOBULIN AND PLATELET FACTOR-4
    DAWES, J
    SMITH, RC
    PEPPER, DS
    [J]. THROMBOSIS RESEARCH, 1978, 12 (05) : 851 - 861
  • [16] DETMERS PA, 1991, J IMMUNOL, V147, P4211
  • [17] AMINO-ACID SEQUENCE OF HUMAN PLATELET FACTOR 4
    DEUEL, TF
    KEIM, PS
    FARMER, M
    HEINRIKSON, RL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (06) : 2256 - 2258
  • [18] PLATELET FACTOR-4 IS CHEMOTACTIC FOR NEUTROPHILS AND MONOCYTES
    DEUEL, TF
    SENIOR, RM
    CHANG, D
    GRIFFIN, GL
    HEINRIKSON, RL
    KAISER, ET
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (07): : 4584 - 4587
  • [19] LIMITED AND DEFINED TRUNCATION AT THE C-TERMINUS ENHANCES RECEPTOR-BINDING AND DEGRANULATION ACTIVITY OF THE NEUTROPHIL-ACTIVATING PEPTIDE-2 (NAP-2) - COMPARISON OF NATIVE AND RECOMBINANT NAP-2 VARIANTS
    EHLERT, JE
    PETERSEN, F
    KUBBUTAT, MHG
    GERDES, J
    FLAD, HD
    BRANDT, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (11) : 6338 - 6344
  • [20] Ehlert JE, 1998, J IMMUNOL, V161, P4975